Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Infusion of Mesenchymal Stem Cells as Treatment for Steroid-Resistant Grade II to IV Acute GVHD or Poor Graft Function: a Multicenter Phase II Study

NCT00603330 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT00603330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00603330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Infusion of Mesenchymal Stem Cells as Treatment for Steroid-Resistant Grade II to IV Acute GVHD or Poor Graft Function: a Multicenter Phase II Study
Lead sponsor
University of Liege
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2008
Completion date
August 31, 2024
Enrollment
100 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host disease, low donor t-cell chimerism, poor graft function